Alphatec Holdings, Inc. operates primarily through its subsidiaries, including Alphatec Spine, to advance minimally invasive and open spine surgery techniques. The company's core product segments include spinal implants and fixation systems, biologics that promote bone growth, and advanced surgical instruments. A key differentiator is its Alpha InformatiX product platform, which features the EOS full-body imaging system and the SafeOp Neural InformatiX System for automated neuromonitoring during procedures. By integrating hardware, software, and biologics, Alphatec aims to improve surgical predictability and patient outcomes in the treatment of degenerative conditions, congenital deformities, and spinal trauma. The company primarily serves surgeons and hospitals, generating the majority of its revenue from the United States.
